Table 3.
Underlying Disease and Medication
| VT/VF group (n=114) |
Non-VT/VF group (n=3,061) |
P-value | |
|---|---|---|---|
| Underlying disease | |||
| Ischemic heart disease | 22 (19) | 510 (17) | 0.46 |
| CKD (grade 3–5) | 82 (72) | 1,335 (44) | <0.0001* |
| Hypertension | 69 (61) | 2,033 (66) | 0.25 |
| Diabetes mellitus | 41 (36) | 1,084 (35) | 0.86 |
| Dyslipidemia | 51 (45) | 1,585 (52) | 0.22 |
| Prior medications | |||
| ARB/ACEI | 37 (32) | 956 (31) | 0.78 |
| β-blockers | 18 (16) | 434 (14) | 0.63 |
| CCB | 34 (30) | 1,056 (34) | 0.30 |
| Statins | 30 (26) | 704 (23) | 0.43 |
Data given as n (%). *P<0.05. Abbreviations as in Tables 1,2.